Deal Making in a New Decade: Lessons Learned and Planning for Tomorrow

4:00 PM - 5:00 PM (EST), Tuesday, February 16, 2021
The emergence of COVID-19 disrupted the status quo for businesses across the industry. With record collaboration and innovation, companies have shown they can adapt to this new landscape. PwC data showed a stark decline in M&A activity from previous years. What do these adaptations and challenges mean for the future? Attend to hear more on how companies and investors consider priorities for 2021 and beyond.
Moderator
photo
Senior Reporter
BioPharma Dive
Speakers
photo
Presenter
Self
photo
Senior Reporter
BioPharma Dive
photo
Global Head of Life Sciences M&A
Citi
photo
Vice President, Corporate Developmment
Bristol Myers Squibb Company
photo
Partner
PricewaterhouseCoopers, LLP
photo
Chief Business Officer
Jnana Therapeutics